{"slideshow_credits": null, "snippet": "The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market.", "abstract": "Food and Drug Admin approves drug Zarxio, produced by Sandoz, first so-called biosimilar drug approved for use in United States; drug helps prevent infections in cancer patients undergoing chemotherapy treatment, and its approval will open door to new class of potentially cheaper biologic drugs, which are made using living cells and not synthesized from chemicals like typical drugs.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Sabrina", "role": "reported", "lastname": "TAVERNISE", "rank": 1, "organization": ""}, {"firstname": "Andrew", "role": "reported", "lastname": "POLLACK", "rank": 2, "organization": ""}], "original": "By SABRINA TAVERNISE and ANDREW POLLACK", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/03/07/health/fda-approves-zarxio-first-biosimilar-drug.html", "lead_paragraph": "The approval paves the way for alternatives to an entire class of complex and costly drugs to go on the market.", "headline": {"main": "F.D.A. Approves Zarxio, Its First Biosimilar Drug", "print_headline": "F.D.A. Clears \u2018Biosimilar\u2019 Medication, Its First Ever"}, "_id": "54f9cffd38f0d81f0d7a63d6", "word_count": "1126", "multimedia": [{"height": 126, "url": "images/2015/03/07/science/06FDA/06FDA-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/03/07/science/06FDA/06FDA-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 398, "url": "images/2015/03/07/science/06FDA/06FDA-articleLarge.jpg", "legacy": {"xlarge": "images/2015/03/07/science/06FDA/06FDA-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "398"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/03/07/science/06FDA/06FDA-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2015/03/07/science/06FDA/06FDA-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-03-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "subject", "value": "Cancer", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Chemotherapy", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3"}, {"name": "organizations", "value": "Sandoz International GmbH", "is_major": "Y", "rank": "4"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "5"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Generic Brands and Products", "is_major": "N", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}